Vaughan, Canada (PressExposure) October 22, 2009 -- Prism Medical Ltd. announced today that the directors have approved payment of a dividend of $0.075 per common share on November 5, 2009 to the shareholders of record on October 28, 2009.
Prism also announced today that the board of directors approved the appointment of Raymond James & Associates, Inc. to act as a financial advisor to the company. In such capacity, Raymond James & Associates, Inc. will independently assess the value of the company and review strategic alternatives with a view to increasing shareholder liquidity and maximizing shareholder value.
Forward-looking Information: Certain statements in this release may constitute forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors, which may cause actual results, performance or achievements of Prism to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements.
Press Contact: Andrew McIntyre President, Chief Executive Officer and Chairman Prism Medical Ltd Vaughan, ON Tel: (416) 260-2145 ext. 235 Fax: (416) 260-9195 firstname.lastname@example.org http://www.prismmedicalltd.com